Zurcher Kantonalbank (Zurich Cantonalbank) Pacific Biosciences Of California, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 77,947 shares of PACB stock, worth $113,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,947
Previous 64,031
21.73%
Holding current value
$113,802
Previous $108,000
31.48%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
256MCall Options Held
3.05MPut Options Held
1.71M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36MShares$52.6 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$34.5 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$34.2 Million8.16% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.3MShares$31.2 Million0.68% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$29.9 Million0.17% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $328M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...